IDH2 and glioblastoma: Of note, in WHO CNS 5—GBM comprises only wild-type tumors while IDH wild-type (wt) diffuse astrocytic tumors with specific genetic parameters match with GBM diagnosis even in cases that appear histologically lower grade (absence of microvascular proliferation and/or necrosis).